Evidence map›Paper›PMID 39958141›Full record

ArticleCureus2025

Epithelioid Angiosarcoma of the Urinary Bladder After Brachytherapy for Prostatic Carcinoma: A Case Report and Literature Review.

Ali Ramadhan

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Ali RamadhanDepartment of Pathology, Antwerp University Hospital, Edegem, BEL.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angiosarcoma of the urinary bladder is an extremely uncommon entity, with only a limited number of cases reported, making its diagnosis and management particularly challenging. This case report presents a rare occurrence of angiosarcoma within the urinary bladder and discusses its clinical presentation, radiological findings, histopathological features, and possible treatment approach for this challenging malignancy. An 84-year-old male presented at the emergency department with hematuria. Relevant history includes prostate carcinoma Gleason 7 in 2007, treated by brachytherapy. Imaging revealed bilateral hydronephrosis, urinary retention, and an irregular lesion growing through the bladder wall. Histopathology showed a highly cellular, poorly differentiated tumor composed of epithelioid cells. Immunohistochemistry was negative for epithelial, urothelial, and prostate markers. There was positivity for ERG, CD34, CD31, factor VIII, and c-myc, confirming the diagnosis of an epithelioid angiosarcoma. RNA-based sequencing did not reveal gene rearrangements. Follow-up CT showed pulmonary metastatic disease. The patient chose to undergo euthanasia six months after symptoms onset because of the decline in quality of life. We present a rare case of angiosarcoma arising in the urinary bladder, emphasizing the importance of considering this malignant vascular tumor in the differential diagnosis of bladder masses. Accurate diagnosis through histopathological evaluation and immunohistochemical staining is crucial for appropriate management. Characteristic features include its infiltrative vascular phenotype with marked atypia and positive staining for endothelial markers. Further studies are warranted to enhance our understanding of this rare entity and establish optimal treatment strategies.

Indexed as

epitheloid angiosarcomahistopathology and immunohistochemistryhistopathology findingsmalignant vascular tumorradiation-induced sarcomaradiotherapyurinary bladder

Identifiers

PMID39958141
PMCPMC11825224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.